Nosocomial respiratory syncytial virus infection in neonatal units in the United Kingdom

被引:14
|
作者
Thwaites, R [1 ]
Piercy, J
机构
[1] St Marys Hosp, Neonatol Unit, Portsmouth PO3 6AD, Hants, England
[2] Thames Valley Univ, London, England
关键词
nosocomial infection; respiratory syncytial virus;
D O I
10.1080/08035320310021011
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Nosocomial Respiratory Syncytial Virus infections are frequently reported and tend to be more severe, because of comorbidity, such reports, however, are frequently from a single centre. The incidence and outcomes of nosocomial Respiratory Syncytial Virus infection in UK neonatal units over a five year period were estimated by interrogating the Capse Health Care Knowledge Systems database, which contains anonymised details of 55% of UK hospital admissions. A total of 79,642 admissions commenced on the infants' date of birth and contained an ICD-10 code for low birth weight or immaturity. Thirty-seven of the 79,642 admissions also contained a Respiratory Syncytial Virus code. Two (5.4%) with Respiratory Syncytial Virus and 2,736 (3.4%) without Respiratory Syncytial Virus died. Survivors with Respiratory Syncytial Virus codes experienced significantly increased length of stay. In the extreme immaturity sub-group the length of stay was 117.5 days with Respiratory Syncytial Virus and 51.3 days without Respiratory Syncytial Virus ( p = 0.0002). In the low birth weight or other preterm sub-group the length of stay with Respiratory Syncytial Virus was 69.2 and without Respiratory Syncytial Virus 14.7 days ( p < 0.0001). The observed low rate for nosocomial Respiratory Syncytial Virus (0.46/1000 admissions) should be regarded as a minimum. The increased length of stay in infants with Respiratory Syncytial Virus infection emphasises that units should have guidelines to prevent and deal with Respiratory Syncytial Virus outbreaks.
引用
收藏
页码:23 / 25
页数:3
相关论文
共 50 条
  • [31] Clinical impact and direct costs of nosocomial respiratory syncytial virus infections in the neonatal intensive care unit
    Comas-Garcia, Andreu
    Aguilera-Martinez, Jose, I
    Escalante-Padron, Francisco J.
    Lima-Rogel, Victoria
    Gutierrez-Mendoza, Luis M.
    Noyola, Daniel E.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2020, 48 (09) : 982 - 986
  • [32] Respiratory Syncytial Virus Infection: An Update
    Soni, Akshita
    Kabra, S. K.
    Lodha, Rakesh
    INDIAN JOURNAL OF PEDIATRICS, 2023, 90 (12): : 1245 - 1253
  • [33] Management of respiratory syncytial virus infection
    Kimpen, JLL
    CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (03) : 323 - 328
  • [34] Prevention of respiratory syncytial virus infection
    Samson, L.
    PAEDIATRICS & CHILD HEALTH, 2009, 14 (08) : 521 - 526
  • [35] RESPIRATORY SYNCYTIAL VIRUS-INFECTION
    KAUL, A
    SCOTT, R
    GALLAGHER, M
    SCOTT, M
    CLEMENT, J
    OGRA, PL
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1978, 132 (11): : 1088 - 1090
  • [36] Respiratory syncytial virus infection in adults
    Falsey, AR
    Walsh, EE
    CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) : 371 - +
  • [37] Severe respiratory syncytial virus infection
    Chabernaud, JL
    ARCHIVES DE PEDIATRIE, 2003, 10 (05): : 468 - 469
  • [38] Ribavirin for respiratory syncytial virus infection
    Ventura, F
    Cheseaux, JJ
    Cotting, J
    Guignard, JP
    ARCHIVES DE PEDIATRIE, 1998, 5 (07): : 809 - 809
  • [39] Bovine respiratory syncytial virus infection
    Valarcher, Jean-Francois
    Taylor, Geraldine
    VETERINARY RESEARCH, 2007, 38 (02) : 153 - 180
  • [40] Respiratory syncytial virus infection and immunity
    Gonzalez, Pablo A.
    Bueno, Susan M.
    Carreno, Leandro J.
    Riedel, Claudia A.
    Kalergis, Alexis M.
    REVIEWS IN MEDICAL VIROLOGY, 2012, 22 (04) : 230 - 244